Today at IDWeek, Curtis J. Donskey, MD, Professor of Medicine at Case Western Reserve University and Infectious Disease Physician at the Louis Stokes Cleveland VA Medical Center, presented new research on a novel surface disinfectant that is as effective against C. diff spores, MRSA and CRE as a standard bleach product, but less damaging to surfaces and leaves less residue on surfaces.
New Data on Novel Surface Disinfectant Presented at IDWeek 2017™
Researchers from Case Western Reserve University and the Louis Stokes Cleveland VA Medical Center presented new data demonstrating the efficacy of Clorox Healthcare® Fuzion™ Cleaner Disinfectant at IDWeek 2017™. The study showed that Clorox Healthcare® Fuzion™ Cleaner Disinfectant was as effective for killing Clostridium difficile (C. difficile) spores, methicillin-resistant Staphylococcus aureus, and carbapenem-resistant Escherichia coli as a standard bleach product, but was less damaging to surfaces and left less residue on surfaces.1
Both bleach formulations reduced each of the pathogens by ≥6.0 log10CFU with a two minute contact time. An assessment of real-world materials compatibility of the products by repeated spray applications on a hospital mattress, formica bedside table, and textiles, found that Fuzion caused minimal to no adverse effects with up to 60 applications. Personnel using the products also reported that Fuzion left much less residue after use and was more tolerable than the standard bleach product.
The research team led by Curtis J. Donskey, MD, Professor of Medicine at Case Western Reserve University and Infectious Disease Physician at the Louis Stokes Cleveland VA Medical Center, presented the findings as a poster abstract on October 5th, 2017 at the IDWeek conference in San Diego.
“Contaminated surfaces are a potential source for dissemination of pathogens in the healthcare environment,” said Dr. Donskey. “Our results confirm the product’s efficacy against clinically relevant healthcare pathogens and suggest that Fuzion may provide an alternative sporicidal disinfectant for facilities concerned about surface compatibility.”
Fuzion is the next generation of bleach and the first product of its kind to combine trusted bleach efficacy against tough-to-kill pathogens with the aesthetics required for broad use throughout healthcare facilities. Fuzion is Environmental Protection Agency-registered to kill C. difficile spores in two minutes, the fastest kill time available,2 and 35 other pathogens in one minute.
About IDWeek 2017™
IDWeek 2017™ is an annual meeting of the Infectious Diseases Society of America (IDSA), the Society for Healthcare Epidemiology of America (SHEA), the HIV Medicine Association (HIVMA) and the Pediatric Infectious Diseases Society (PIDS). With the theme “Advancing Science, Improving Care,” IDWeek features the latest science and bench-to-bedside approaches in prevention, diagnosis, treatment, and epidemiology of infectious diseases, including HIV, across the lifespan. IDWeek 2017 takes place October 4-8 at the San Diego Convention Center in San Diego. For more information, visit www.idweek.org.
About Clorox Healthcare
Building on a century-long legacy in cleaning and disinfecting, Clorox Healthcare offers a wide range of products to help stop the spread of infection in healthcare facilities. From comprehensive surface disinfection to advanced ultraviolet technology, we are committed to providing efficacious solutions to the healthcare community. For more information, visit www.CloroxHealthcare.com or follow @CloroxHealth on Twitter.
1 Mana, T.S.; Cadnum, J.L.; Piedrahita, C.; Jencson, A.L.; Donskey, C.J. An equally effective but better tolerated formulation of bleach. Poster session presented at: IDWeek 2017 Oct. 4-8; San Diego, CA.
2 Based on EPA Master Label Comparison as of 4/19/2016.
News From Our Partners